Company facts
- Headquarters
- Foster City, California
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 882095
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 36
News 8 of 90
Prospectuses and Registrations 8 of 21
- S-3ASR Automatic shelf registration Aug 6, 2026
- 424B5 Prospectus supplement for an offering May 18, 2026
- FWP Free writing prospectus May 14, 2026
- 424B5 Prospectus supplement for an offering May 14, 2026
- S-8 Registration statement for an employee plan May 7, 2026
- 424B5 Prospectus supplement for an offering Nov 15, 2024
- FWP Free writing prospectus Nov 13, 2024
- 424B5 Prospectus supplement for an offering Nov 13, 2024
Proxies 8 of 30
- DEFA14A Extra proxy material Mar 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 20, 2026
- PX14A6G Shareholder's own proxy material Apr 7, 2025
- DEFA14A Extra proxy material Mar 27, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2025
- DEFA14A Extra proxy material Mar 28, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2024
- PRE 14A Preliminary proxy statement Mar 18, 2024
Ownership 8 of 765
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 4 Insider reported a trade Aug 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 7, 2026
- 4 Insider reported a trade Aug 4, 2026
- 144 Notice of a proposed sale of restricted stock Aug 3, 2026
Other 8 of 59
Everything here comes from Gilead Sciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.